Clinical Trial Update: An Open Enrollment Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency [Phase 3]

View source ↗

Summary

This is a Phase 3 open enrollment study of Factor XIII Concentrate for congenital Factor XIII deficiency sponsored by CSL Behring; results were posted after stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Factor Xiii Deficiency

Drugs mentioned

• Factor XIII concentrate (Coagulation factor XIII concentrate)

Snippet

Sponsor: CSL Behring | Conditions: Factor XIII Deficiency | Phase 3 | Status: COMPLETED | Results posted: 2012-10-12